Rudan, I, et al.
Epidemiology and etiology of childhood pneumonia. Bulletin of the World Health Organization
2008; 86: 408–416.
Nair, H, et al.
Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet
2013; 381: 1380–1390.
Makinen, TM, et al.
Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections. Respiratory Medicine
2009; 103: 456–462.
Tang, JW, Loh, TP. Correlations between climate factors and incidence – a contributor to RSV seasonality. Reviews in Medical Virology
2014; 24: 15–34.
te Beest, DE, et al.
Driving factors of influenza transmission in the Netherlands. American Journal of Epidemiology
2013; 178: 1469–1477.
Tulloh, RM, Bury, S. Prevention and prophylaxis of respiratory syncytial virus in pediatric cardiology: a UK perspective. Future Cardiology
2014; 10: 235–242.
Geevarghese, B, Weinberg, A. Cell-mediated immune responses to respiratory syncytial virus infection: Magnitude, kinetics, and correlates with morbidity and age. Human Vaccines & Immunotherapeutics
2014; 10: 1047–1056.
Takeyama, A, et al.
Clinical and epidemiologic factors related to subsequent wheezing after virus-induced lower respiratory tract infections in hospitalized pediatric patients younger than 3 years. European Journal of Pediatrics
2014; 173: 959–966.
Chang, AB, et al.
Improving the diagnosis, management, and outcomes of children with pneumonia: where are the gaps?
Frontiers in Pediatrics
2013; 1: 29.
Kellner, J. Update on the success of the pneumococcal conjugate vaccine. Paediatrics & Child Health
2011; 16: 233–240.
Ladhani, SN, et al.
Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerging Infectious Diseases
2013; 19: 61–68.
Hoen, AG, et al.
Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada. Canadian Medical Association Journal
2011; 183: E1025–1032.
De, Wals P, et al.
Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada. Vaccine
2012; 30: 6416–6420.
De, Wals P, et al.
Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatric Infectious Disease Journal
2008; 27: 963–968.
De Wals, P, et al.
Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programs. Canadian Journal of Public Health
2009; 100: 413–416.
Coughlin, SS, et al.
Regression methods for estimating attributable risk in population-based case-control studies: a comparison of additive and multiplicative models. American Journal of Epidemiology
1991; 133: 305–313.
Guo, Z, Gill, TM, Allore, HG. Modeling repeated time-to-event health conditions with discontinuous risk intervals. An example of a longitudinal study of functional disability among older persons. Methods of Information in Medicine
2008; 47: 107–116.
Rothman, KJ, Greenland, S, Lash, TL. Ecologic studies. Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins, 2008, pp. 596–619.
Boshuizen, HC, Feskens, EJ. Fitting additive Poisson models. Epidemiologic Perspectives & Innovations
2010; 7: 4.
Gay, NJ, et al.
Estimating deaths due to influenza and respiratory syncytial virus. Journal of the American Medical Association
2003; 289: 2499; author reply 500–502.
Leader, S, Kohlhase, K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatric Infectious Disease Journal
2002; 21: 629–632.
Shay, DK, et al.
Bronchiolitis-associated hospitalizations among US children, 1980–1996. Journal of the American Medical Association
1999; 282: 1440–1446.
Ogra, PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatric Respiratory Reviews
2004; 5 (Suppl. A): S119–S126.
Moore, HC, et al.
Use of data linkage to investigate the aetiology of acute lower respiratory infection hospitalisations in children. Journal of Paediatrics and Child Health
2012; 48: 520–528.
Ralston, SL, et al.
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics
2014; 134: e1474–1502.
Swingler, GH, Hussey, GD, Zwarenstein, M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet
1998; 351: 404–408.
Pneumonia Vaccine Trial Investigators' Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. Department of Vaccines and Biologicals, World Health Organization, 2001.
Grijalva, CG, Griffin, MR. Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. Expert Review of Vaccines
2008; 7: 83–95.
Falagas, ME, et al.
Effect of meteorological variables on the incidence of respiratory tract infections. Respiratory Medicine
2008; 102: 733–737.
Kim, PE, et al.
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clinical Infectious Diseases
1996; 22: 100–106.
Nicoli, EJ, et al.
Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK. Journal of Infection
2013; 66: 512–520.
Ampofo, K, et al.
Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics
2008; 122: 229–237.
Weinberger, DM, et al.
Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity. Clinical Infectious Diseases
2014; 58: 188–194.
Peters, TR, et al.
Relative timing of influenza disease by age group. Vaccine
2014; 32: 6451–6456.
Sebastian, R, et al.
Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998–2004. Vaccine
2008; 26: 1397–1403.
Santibanez, P, et al.
Acute care utilization due to hospitalizations for pediatric lower respiratory tract infections in British Columbia, Canada. BMC Health Services Research
2012; 12: 451.
Murray, J, et al.
Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS ONE
2014; 9: e89186.
Zhou, H, et al.
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clinical Infectious Diseases
2012; 54: 1427–1436.
Jefferson, T, et al.
Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews
2012; 8: CD004879.
De, Wals P, et al.
Impact of 2 + 1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine
2014; 32: 1501–1506.
Tregnaghi, MW, et al.
Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial. PLoS Medicine
2014; 11: e1001657.
Palmu, AA, et al.
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3–4 trial. Lancet Infectious Diseases
2014; 14: 205–212.
Black, SB, et al.
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatric Infectious Disease Journal
2002; 21: 810–815.